Product Code: 978-1-68038-961-6
Nerve Repair And Regeneration Market Growth & Trends:
The global nerve repair and regeneration market size is expected to reach USD 20.5 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 12.16% from 2022 to 2030. Demand for neurological disorder therapies owing to the increasing incidence and rising awareness regarding the same will drive the market. Moreover, government funding and reimbursement policies and uninterrupted technological advances are projected to boost market growth.
In January 2016, the EU Horizon 2020 program funded a research project 'Autostem', launched by the NUI Galway's Regenerative Medicine Institute (REMEDI), costing about USD 6.73 million. This project was to develop a robotic stem cell production factory, having an edge over the old traditional techniques. This technique offers prospects for new therapies for a range of diseases, such as cancers, diabetes, and arthritis. Increased R&D and investments by key companies in emerging countries are also driving the market. In July 2018, Stem Cells Australia (SCA) received USD 3 million for stem cell research from the Medical Research Future Fund (MRFF).
In addition, government and private funded organizations are conducting clinical trials to develop a safe and effective therapy for different neurological disorders, such as Stem Cells in Umbilical Blood Infusion for Cerebral Palsy (Phase II) and the usage of Polyethylene glycol (PEG) drug (Phase I) to promote axonal fusion technique to repair peripheral nerve injuries in humans.
Furthermore, in October 2017, Stryker Corporation acquired VEXIM, a France-based medical device company. VEXIM's portfolio is complementary to Stryker's Interventional Spine (IVS) portfolio. With this acquisition, Stryker will strengthen its distribution channels in Eastern Europe, the Middle East, Asia, and Latin America. In January 2018, Boston Scientific Corporation received U.S. FDA approval for the first and only Spectra WaveWriter spinal cord stimulator system. This system is used for paresthesia-based therapy.
Nerve Repair And Regeneration Market Report Highlights:
- In 2021, the neuromodulation and neurostimulation devices product segment led the market due to the increased cases of Central Nervous System (CNS) disorders and awareness regarding mental disorders and available treatments
- The biomaterials product segment is anticipated to expand at the fastest CAGR during the forecast period due to technological advancements and the development of biodegradable polymers that can help enhance spinal stabilization and healing of fractures and reduce hospitalization
- North America led the market in 2021 owing to technological advancements and the advent of new devices. Government initiatives and funding and increased cases of injured CNS, such as injuries to the spinal cord and brain, were some of the major reasons responsible for the regional market growth
- Asia Pacific is expected to be the fastest-growing regional market during the forecast period. The growing geriatric population, technological advancements, and many unmet medical needs are some of the factors driving the regional market
- The combination of therapies including a cocktail of peptides, nerve stimulation techniques, injecting the brain with stem cells, and other techniques that were successful in bringing patients out of coma were to be used
- Existing medical devices were combined with regenerative biological medicines with the objective to achieve such a complex initiative
Table of Contents
Chapter 1. Methodology and Scope
- 1.1 Market Segmentation & Scope
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.4 Information or Data Analysis
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.2 Volume Price Analysis (model 2)
- 1.7 List of Secondary Sources
- 1.8 List of Abbreviations
- 1.9 Objectives
- 1.9.1 Objective - 1
- 1.9.2 Objective - 2
Chapter 2. Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
Chapter 3. Market Variables, Trends & Scope
- 3.1 Market Lineage outlook
- 3.1.1 Parent Market Outlook
- 3.2 Market Segmentation
- 3.3 Penetration & Growth Prospect Mapping
- 3.3.1 Penetration & Growth Prospect Mapping
- 3.4 Regulatory Framework & Reimbursement Scenario
- 3.5 Market Dynamics
- 3.5.1 Market Driver Analysis
- 3.5.1.1 Increasing government fundings and reimbursements
- 3.5.1.2 Increasing incidences of the neurological disorders
- 3.5.1.3 Rising medical tourism
- 3.5.2 Market Restraint Analysis
- 3.5.2.1 Lack of awareness in the patients for treatment of nerve repair and regeneration
- 3.5.2.2 High cost of the treatment and unavailability of trained medical personnel
- 3.6 Business Environment Analysis Tools
- 3.6.1 Porter's Five Forces Analysis
- 3.6.1.1 Bargaining power of buyers: Moderate
- 3.6.1.2 Bargaining power of suppliers: Low
- 3.6.1.3 Competitive rivalry: High
- 3.6.1.4 Threat of new entrants: Moderate
- 3.6.1.5 Threat of substitutes: Moderate
- 3.6.2 PESTEL Analysis
- 3.6.2.1 Political & legal landscape
- 3.6.2.2 Economic landscape
- 3.6.2.3 Social landscape
- 3.6.2.4 Technological landscape
- 3.6.2.5 Environmental landscape
- 3.7 Major Deals & Strategic Alliances Analysis
- 3.7.1 Mergers & Acquisitions
- 3.7.2 Licensing & Partnership
Chapter 4. Nerve Repair And Regeneration Market: Product Analysis
- 4.1 Nerve Repair And Regeneration Product Market Share Analysis, 2021
- 4.2 Nerve Repair And Regeneration Product Market: Segment Dashboard:
- 4.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Product Segment
- 4.3.1 Biosimilars
- 4.3.1.1 Biosimilars market, 2018 - 2030 (USD Million)
- 4.3.2 Neurostimulation & Neuromodulation Devices
- 4.3.2.1 Spinal cord stimulation devices market, 2018 - 2030 (USD Million)
- 4.3.2.2. Deep brain stimulation devices market, 2018 - 2030 (USD Million)
- 4.3.2.3 Sacral nerve stimulation devices market, 2018 - 2030 (USD Million)
- 4.3.2.4 Vagus nerve stimulation devices market, 2018 - 2030 (USD Million)
- 4.3.2.5 Gastric electric stimulation devices market, 2018 - 2030 (USD Million)
Chapter 5. Nerve Repair And Regeneration Market: Surgery Analysis
- 5.1 Nerve Repair And Regeneration Surgery Market Share Analysis, 2021
- 5.2 Nerve Repair And Regeneration Surgery Market: Segment Dashboard
- 5.3 Market Size & Forecasts And Trend Analyses, 2018 - 2030 For The Surgery
- 5.3.1 Direct Nerve Repair/Neurorrhaphy
- 5.3.1.1 Direct nerve repair/Neurorrhaphy market, 2018 - 2030 (USD Million)
- 5.3.2 Nerve Grafting
- 5.3.2.1 Nerve grafting market, 2018 - 2030 (USD Million)
- 5.3.3 Stem Cell Therapy
- 5.3.3.1 Stem cell therapy market, 2018 - 2030 (USD Million)
- 5.3.4 Neurostimulation & Neuromodulation Surgeries
- 5.3.4.1 Neurostimulation & neuromodulation surgeries market, 2018 - 2030 (USD Million)
Chapter 6. Nerve Repair And Regeneration Market: Regional Analysis
- 6.1 Nerve Repair And Regeneration Regional Market Share Analysis, 2021
- 6.2 Nerve Repair And Regeneration Regional Market: Segment Dashboard
- 6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
- 6.4 List of Players at Regional Level
- 6.4.1 North America
- 6.4.2 Europe
- 6.4.3 Asia Pacific
- 6.4.4 Latin America
- 6.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 6.6 Market Size, & Forecasts, And Trend Analysis, 2018 - 2030
- 6.6.1 North America
- 6.6.2 North America Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
- 6.6.2.1 U.S.
- 6.6.2.2 Canada
- 6.7 Europe
- 6.7.1 Europe Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
- 6.7.1.1 U.K.
- 6.7.1.2. Germany
- 6.7.1.3 France
- 6.7.1.4. Italy
- 6.7.1.5 Spain
- 6.8 Asia Pacific
- 6.8.1 Asia Pacific Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
- 6.8.1.1 Japan
- 6.8.1.2 China
- 6.8.1.3 India
- 6.8.1.4 Australia
- 6.8.1.5 South Korea
- 6.9 Latin America
- 6.9.1 Latin America Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
- 6.9.1.1 Brazil
- 6.9.1.2 Mexico
- 6.9.1.3 Colombia
- 6.10 Middle East and Africa
- 6.10.1 MEA Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
- 6.10.1.1 UAE
- 6.10.1.2 Saudi Arabia
- 6.10.1.3 South Africa
Chapter 7. Competitive Analysis
- 7.1 Recent Developments & Impact Analysis, By Key Market Participants
- 7.2 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players
- 7.3 Vendor Landscape
- 7.4 Public Companies
- 7.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
- 7.5 Private Companies
- 7.5.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
- 7.6 Company Profiles
- 7.6.1 CYBERONICS, INC.
- 7.6.1.1 Company overview
- 7.6.1.2 Financial performance
- 7.6.1.3 Product benchmarking
- 7.6.1.4 Strategic initiatives
- 7.6.1.5 SWOT Analysis
- 7.6.2 MEDTRONIC
- 7.6.2.1 Company overview
- 7.6.2.2 Financial performance
- 7.6.2.3 Product benchmarking
- 7.6.2.4 Strategic initiatives
- 7.6.2.5 SWOT Analysis
- 7.6.3 STRYKER
- 7.6.3.1 Company overview
- 7.6.3.2 Financial performance
- 7.6.3.3 Product benchmarking
- 7.6.3.4 Strategic initiatives
- 7.6.3.5 SWOT Analysis
- 7.6.4 AXOGEN CORPORATION
- 7.6.4.1 Company overview
- 7.6.4.2 Financial performance
- 7.6.4.3 Product benchmarking
- 7.6.4.4 Strategic initiatives
- 7.6.4.5 SWOT Analysis
- 7.6.5 ST. JUDE MEDICAL
- 7.6.5.1 Company overview
- 7.6.5.2 Financial performance
- 7.6.5.3 Product benchmarking
- 7.6.5.4 Strategic initiatives
- 7.6.5.5 SWOT Analysis
- 7.6.6 BAXTER
- 7.6.6.1 Company overview
- 7.6.6.2 Financial performance
- 7.6.6.3 Product benchmarking
- 7.6.6.4 Strategic initiatives
- 7.6.6.5 SWOT Analysis
- 7.6.7 BOSTON SCIENTIFIC CORPORATION
- 7.6.7.1 Company overview
- 7.6.7.2 Financial performance
- 7.6.7.3 Product benchmarking
- 7.6.7.4 Strategic initiatives
- 7.6.7.5 SWOT Analysis
- 7.6.8 POLYGANICS
- 7.6.8.1 Company overview
- 7.6.8.2 Financial performance
- 7.6.8.3 Product benchmarking
- 7.6.8.4 Strategic initiatives
- 7.6.9 INTEGRA LIFESCIENCES
- 7.6.9.1 Company overview
- 7.6.9.2 Financial performance
- 7.6.9.3 Product benchmarking
- 7.6.9.4 Strategic initiatives
- 7.6.9.5 SWOT Analysis